AU2002220416A1 - Oncolytic virus - Google Patents

Oncolytic virus

Info

Publication number
AU2002220416A1
AU2002220416A1 AU2002220416A AU2041602A AU2002220416A1 AU 2002220416 A1 AU2002220416 A1 AU 2002220416A1 AU 2002220416 A AU2002220416 A AU 2002220416A AU 2041602 A AU2041602 A AU 2041602A AU 2002220416 A1 AU2002220416 A1 AU 2002220416A1
Authority
AU
Australia
Prior art keywords
oncolytic virus
oncolytic
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002220416A
Inventor
John Cameron Bell
Earl Garnet Brown
Jean Lutamyo Mbisa
David Francis Stodjl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Ottawa
Original Assignee
University of Ottawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Ottawa filed Critical University of Ottawa
Publication of AU2002220416A1 publication Critical patent/AU2002220416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/765—Reovirus; Rotavirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002220416A 2000-12-01 2001-11-30 Oncolytic virus Abandoned AU2002220416A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25013100P 2000-12-01 2000-12-01
US60/250,131 2000-12-01
US32701601P 2001-10-05 2001-10-05
US60/327,016 2001-10-05
PCT/CA2001/001703 WO2002043647A2 (en) 2000-12-01 2001-11-30 Oncolytic virus

Publications (1)

Publication Number Publication Date
AU2002220416A1 true AU2002220416A1 (en) 2002-06-11

Family

ID=26940619

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002220416A Abandoned AU2002220416A1 (en) 2000-12-01 2001-11-30 Oncolytic virus
AU2002243257A Abandoned AU2002243257A1 (en) 2000-12-01 2001-12-03 Oncolytic virus

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2002243257A Abandoned AU2002243257A1 (en) 2000-12-01 2001-12-03 Oncolytic virus

Country Status (5)

Country Link
EP (1) EP1339736A2 (en)
JP (1) JP2004519431A (en)
AU (2) AU2002220416A1 (en)
CA (1) CA2430495A1 (en)
WO (2) WO2002043647A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2002953436A0 (en) 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
WO2005111200A1 (en) * 2004-05-17 2005-11-24 Universite De Montreal Novel strains of reoviruses and methods of uses thereof
CA2617600A1 (en) 2005-08-01 2007-09-07 University Technologies International, Inc. Attenuated reovirus
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
JP5577103B2 (en) 2007-03-12 2014-08-20 オンコリティクス バイオテク，インコーポレーテッド Reovirus with modified sequence
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
WO2019237063A1 (en) * 2018-06-07 2019-12-12 Emory University Modified reoviruses, particles, and uses in treating proliferative disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
US6136307A (en) * 1997-08-13 2000-10-24 Oncolytics Biotech Inc. Reovirus for the treatment of cellular proliferative disorders
WO1999045783A1 (en) * 1998-03-12 1999-09-16 The Trustees Of The University Of Pennsylvania Producer cells for replication selective viruses in the treatment of malignancy

Also Published As

Publication number Publication date
CA2430495A1 (en) 2002-06-06
WO2002050304A2 (en) 2002-06-27
WO2002043647A2 (en) 2002-06-06
WO2002050304A3 (en) 2002-11-28
WO2002043647A3 (en) 2003-01-03
JP2004519431A (en) 2004-07-02
AU2002243257A1 (en) 2002-07-01
EP1339736A2 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
AU2002210450A1 (en) Maintaining virus detection software
AU2001262847A1 (en) Language-understanding
AU2001282528A1 (en) Compounds having anti-hepatitis c virus effect
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AUPQ912000A0 (en) Improved virus like particles
AU2001239310A1 (en) Decahydro-isoquinolines
AU2002221749A1 (en) Synthetic viruses and uses thereof
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
IL153879A0 (en) Modified virus
AU2001258924A1 (en) Microsatellite-aflp
AU2002306709A1 (en) Oncolytic rna replicons
AU2001240791A1 (en) Sequence
AU2002243257A1 (en) Oncolytic virus
AU2001262689A1 (en) Oligopeptides
AUPR160400A0 (en) Plant virus promoter
AU2001246864A1 (en) Hypotensors
GB0001475D0 (en) Virus strains
AU2002222139A1 (en) Hcv vaccines
AU2002354841A1 (en) Engineering oncolytic viruses
AU2001262711A1 (en) Cytoprotectors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001260192A1 (en) Glycinamides
AU2002224845A1 (en) Viral expression system